LATS2 and esophageal squamous cell carcinoma: Moreover, Gao et al. demonstrated that the overexpression of miR-31 is an oncogene in ESCC, repressing the expression of LATS2 by the Hippo pathway and activating epithelial–mesenchymal transition (71).